Brad Hirsch, M.D.

 Dr. Hirsch is Co-Founder and CEO of SignalPath Research, a company leveraging technology to make clinical trials more efficient and effective. He is also a medical oncologist, principal investigator, and senior advisor to Highlander Partners, a private equity fund based in Dallas, Texas. Prior to his present focus, he has held leadership roles in technology companies and academics including Flatiron Health, a Google-backed data and analytics company that sold to Roche for $2.1 billion in 2018, and the Duke University School of Medicine.  Across all of his roles, he has focused on the use of data and novel technologies to advance the frontier in medicine.